Arun Krishna
Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit
Responsibilities
Arun Krishna, Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit, is responsible for overseeing all lung cancer US sales and the commercialization of TAGRISSO, DATROWAY, and future lung cancer indications.
Prior Experience
Before assuming his current role in 2022, Arun was the Head of Oncology in the UK where he led an integrated team across Commercial, Medical, Access, Diagnostics & Business Innovation in five therapeutic areas. Prior to joining AstraZeneca in 2019 he held various clinical development, new product strategy and market access roles at Novartis and Merck.
Education
- PhD, Philosophy, Mathematics and Biostatistics, North Carolina State University
- Bachelor of Science, Engineering
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.